| Home |
| Business |
| Sciences |
| Regulatory & IPR |
| Market Studies |
| Open Source |
| News in Brussels |
| Technological partnership |
| European opportunities |
| IPR Support |
| Strategic Information |
| Bio&Pharma e-Newsletter |
| Legal note |
| Bio&Pharma Companies |
| Bio&Pharma Universities |
| Bio&Pharma Organisations |
| BEA-ABE-BAO |
| MedTech Universities |
| MedTech Organisations |
| MedTech Companies |
Tuesday, 22 June 2010
For a successful infection, bacteria must outwit the immune system of the host. To this aim, they deliver so-called virulence factors through a transport channel located in the bacterial membrane. In some bacteria this transport channel is formed like a syringe, enabling them to inject virulence factors directly into the host cell. Scientists from the Max Planck Society and the Federal Institute for Materials Research and Testing have now succeeded for the first time in elucidating basic principles of the assembly of this transport channel. This is an important starting point for the development of new drugs that might interfere considerably earlier than antibiotics in the course of infection. (Nature Structural & Molecular Biology, 13 June 2010)
The genetic secrets behind eye colour
Tuesday, 22 June 2010
EU-funded scientists have discovered new genes involved in determining human eye colour. More than just blue, green and brown, the team believes that our eye colour has many more dimensions and variations than previously documented. This new lead has the potential to be used in forensic science, providing investigators with a 'face' to genetic clues left at a crime scene. Findings from the study are published in the journal PLoS (Public Library of Science) Genetics.
Brain circuits that control habitual learning identified
Tuesday, 22 June 2010
EU-funded scientists have identified two brain circuits that are involved in habitual learning such as finding our way to and from work. The new findings, published in the journal Neuron, have implications for the study of Parkinson's disease, substance abuse and many psychiatric disorders.
New strategy to fight cancer drug resistance
Tuesday, 22 June 2010
Scientists at Dana-Farber Cancer Institute have found a way to disable a common protein that often thwarts chemotherapy treatment of several major forms of cancer.
Why cystic fibrosis patients live longer in some countries
Wednesday, 24 March 2010
The largest study to date of cystic fibrosis (CF) says that people suffering from the disease live longer in some European countries than in others, mainly due to earlier mortality and differences in access to care and its quality. The research, which was supported under the Sixth Framework Programme (FP6), is published in The Lancet journal.
<< Start < Prev 1 2 3 4 5 6 7 8 Next > End >>
Results 1 - 9 of 67